Company/Division name | Primal Pharma Solutions |
Type of work | Manufacturing |
If manufacturing, is the company a contract manufacturer? | Yes |
Reshoring category: | Transplant |
Year reshoring announced: | 2015 |
Domestically, the work will be done: | In-house |
Capital investment ($): | 25 |
Country(ies) from which reshored: | India |
City reshored to: | Lexington |
State(s) reshored to: | KY |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals, Medical Equipment & Supplies |
Product(s) reshored | Sterile Drug Products |
What domestic positive factors made reshoring more attractive? | Proximity to customers/market, Skilled workforce availability/training |